Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-02

Clinical Trial Update: A Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients With Alzheimer's Disease. [NA]

View source ↗

Summary

A study evaluating silkworm pupa powder as a nutritional intervention for patients with Alzheimer's disease, including those with sarcopenia, is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silkworm Pupa Powder

Snippet

Sponsor: Zhejiang Hospital | Conditions: AD - Alzheimer's Disease, Sarcopenia | NA | Status: RECRUITING